PFG Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

PFG Investments’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,000	Closed	-$3.95K	–	1334
2026 Q1	$3.95K	Buy	+16,000	New	+$6.37K	﹤0.01%	1189

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

PFG Investments's SGMO Position: Q2 2026 in Review

PFG Investments sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 16,000 shares — an estimated $3.95K sold.

PFG Investments first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $3.95K in Q1 2026. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

PFG Investments reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
PFG Investments sold 16,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $3.95K.
PFG Investments first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
PFG Investments's SANGAMO THERAPEUTICS INC position peaked at $3.95K in Q1 2026.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.